Yongtao Han

Academic / Other · 7 registered clinical trials.

Status	Trial	Phase	Started
Completed	Development and Validation of a Survival Prediction Model for Esophageal Cancer Patients After Esophagectomy Survivorship	—	2023-12-01
Unknown	RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY the Records of Esophageal Cancer	—	2022-10-01
Completed	Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc Esophageal Cancer	—	2022-05-01
Completed	The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esopha Esophageal Cancer	—	2022-05-01
Completed	Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC Esophageal Squamous Cell Carcinoma (ESCC)	N/A	2018-03-01
Completed	Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC Esophageal Squamous Cell Carcinoma (ESCC)	Phase 3	2018-01-01
Completed	Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years Esophageal Squamous Cell Carcinoma, Esophagectomy, Radiotherapy	—	2009-01-01